Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. - Lu, Jing; Qiu, Huiying; Wang, Ying; Zhou, Xin; Dai, Haiping; Lu, Xuzhang; Yang, Xiaofei; Gu, Bin; Hong, Ming; Miao, Miao; Lu, Ruinan; Wang, Jun; et al. (Journal of Hematology & Oncology, 2024)